Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Aged (1)
- Animals (1)
- Attention Deficit Disorder with Hyperactivity (1)
- Attention deficit disorder with hyperactivity (1)
- Biomarkers (1)
-
- Chronic Disease (1)
- Chronic disease (1)
- Diabetes Mellitus, Type 2 (1)
- Diabetes mellitus (1)
- Endocannabinoids (1)
- Endovascular Procedures (1)
- Endovascular procedures (1)
- Female (1)
- Ischemia (1)
- Lipoprotein(a) (1)
- Lower Extremity (1)
- Lower extremity (1)
- Male (1)
- Marijuana Abuse (1)
- Marijuana Use (1)
- Marijuana abuse (1)
- Marijuana use (1)
- Middle Aged (1)
- Middle aged (1)
- Peripheral Arterial Disease (1)
- Peripheral arterial disease (1)
- Predictive Value of Tests (1)
- Predictive value of tests (1)
- Prospective Studies (1)
Articles 1 - 2 of 2
Full-Text Articles in Lipids
Prognostic Value Of Lipoprotein(A) For Cardiovascular Events After Lower Limb Revascularization In Diabetic Patients With Chronic Limb-Threatening Ischemia, Federico Biscetti, Maria Margherita Rando, Maria Anna Nicolazzi, Flavia Angelini, Roberto Iezzi, Luis H. Eraso, Paul J. Dimuzio, Dario Pitocco, Massimo Massetti, Antonio Gasbarrini, Andrea Flex
Prognostic Value Of Lipoprotein(A) For Cardiovascular Events After Lower Limb Revascularization In Diabetic Patients With Chronic Limb-Threatening Ischemia, Federico Biscetti, Maria Margherita Rando, Maria Anna Nicolazzi, Flavia Angelini, Roberto Iezzi, Luis H. Eraso, Paul J. Dimuzio, Dario Pitocco, Massimo Massetti, Antonio Gasbarrini, Andrea Flex
Department of Surgery Faculty Papers
BACKGROUND: Chronic limb-threatening ischemia (CLTI) presents a major clinical challenge in patients with Type 2 Diabetes Mellitus (T2DM), requiring lower extremity revascularization (LER) to mitigate adverse cardiovascular and limb outcomes. Lipoprotein(a) (Lp(a)) has been implicated in cardiovascular risk, but its role in patients with T2DM and CLTI undergoing revascularization remains unclear. Thus, this study aimed to investigate the prognostic value of Lp(a) levels in diabetic CLTI patients for major adverse cardiovascular events (MACE), major adverse limb events (MALE), or both after LER.
METHODS: In this prospective cohort study of 158 individuals with T2DM and CLTI undergoing LER, baseline clinical data …
Attention Deficit Hyperactivity Disorder, Cannabis Use, And The Endocannabinoid System: A Scoping Review, Jennie Ryan, Mitchell Fruchtman, Andrea Sparr-Jaswa, Amy Knehans, Brooke Worster
Attention Deficit Hyperactivity Disorder, Cannabis Use, And The Endocannabinoid System: A Scoping Review, Jennie Ryan, Mitchell Fruchtman, Andrea Sparr-Jaswa, Amy Knehans, Brooke Worster
Department of Medicine Faculty Papers
There is emerging evidence that the endocannabinoid system (ECS) plays a significant role in the pathophysiology of many psychiatric disorders, including attention deficit hyperactivity disorder (ADHD). Increasing evidence suggests that a number of neurobiological correlates between endogenous cannabinoid function and cognitive dysfunction are seen in ADHD, making the ECS a possible target for therapeutic interventions. Cannabis use and cannabis use disorder are more prevalent in individuals with ADHD, compared to the general population, and there is growing popular perception that cannabis is therapeutic for ADHD. However, the relationship between cannabis use and ADHD symptomology is poorly understood. Further understanding of …